Clinical Trials on Congenital Dyserythropoietic Anemia Type 1 in Mexico
Total 80 results
-
Hospital General Dr. Manuel Gea GonzálezUnknownEar Cartilage | Platelets | Microtia-AnotiaMexico
-
Dra. Olga Graciela Cantu RodriguezCompleted
-
University of New MexicoAmerican Diabetes AssociationCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Mexico
-
Universidad Juárez Autónoma de TabascoCompletedMetabolic Syndrome | Insulin Resistance | Type 1 DiabetesMexico
-
CephalonCompletedPain | Cancer | Sickle Cell Anemia | Severe BurnsUnited States, Canada, Puerto Rico
-
Repros Therapeutics Inc.TerminatedAnemia | Uterine FibroidsMexico
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
Universidad Juárez Autónoma de TabascoCompletedLatent Autoimmune DiabetesMexico
-
InLight SolutionsCompletedHealthy | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Prediabetic State (IGT)United States
-
Instituto Nacional de Cardiologia Ignacio ChavezEchoNous Inc.RecruitingCardiorenal Syndrome Type 1Mexico
-
InLight SolutionsUnknownType 1 Diabetes | Type 2 Diabetes | Gestational DiabetesUnited States
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
David Sanchez GarciaInstituto Mexicano del Seguro SocialCompletedDiabetes Mellitus, Type 1Mexico
-
Andromeda Biotech Ltd.CompletedType 1 Diabetes MellitusUnited States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
National Institute of Diabetes and Digestive and...Completed
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host DiseaseKorea, Republic of, Italy, Belgium, Japan, Germany, Australia, Bulgaria, Chile, China, Denmark, Greece, Hungary, Israel, Lebanon, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Thailand, India, Mexico, Turkey, Fran...
-
MacroGenicsEli Lilly and CompanyTerminatedType 1 Diabetes MellitusUnited States, Israel, United Kingdom, Poland, France, Germany, Belgium, Finland, India, Ukraine, Spain, Czechia, Italy, Mexico, Netherlands, Romania
-
MacroGenicsEli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Spain, Israel, Canada, India, Czechia, Ukraine, Sweden, Latvia, Mexico, Germany, Poland, Romania, Estonia, Netherlands, United Kingdom
-
Sangamo TherapeuticsJuvenile Diabetes Research FoundationCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic PolyneuropathyUnited States, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Sangamo TherapeuticsCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic PolyneuropathyUnited States, Mexico
-
University of New MexicoUniversity of California, San FranciscoRecruitingCerebral Cavernous MalformationUnited States
-
Mannkind CorporationCompletedType 1 Diabetes MellitusUnited States, Brazil, Russian Federation, Ukraine
-
SanofiCompletedDiabetes Mellitus, Type 1Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
-
Grifols Therapeutics LLCTerminatedType 1 Diabetes MellitusUnited States
-
Mannkind CorporationCompletedDiabetes, Type 2 | Diabetes, Type 1United States, Spain, Canada, Russian Federation, Czech Republic, Poland, Ukraine, United Kingdom
-
University of New MexicoNational Institute of Neurological Disorders and Stroke (NINDS); University...TerminatedCerebral Cavernous Malformations | Cavernous Angioma, Familial | Cerebral Cavernous HemangiomaUnited States
-
Janssen Sciences Ireland UCCompletedImmunodeficiency Virus Type 1, HumanUnited States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetic RetinopathyUnited States, United Kingdom, Spain, Poland, Slovakia, Australia, Puerto Rico
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Mannkind CorporationCompletedType 1 Diabetes | Type 2 DiabetesUnited States, Brazil, Canada, Russian Federation
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, Israel, Mexico, Russian Federation, Argentina, Italy
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of Sao Paulo and other collaboratorsActive, not recruitingHPV Infection | HIV-1-infection | HPV Positive Oropharyngeal Squamous Cell CarcinomaBrazil, Mexico, Puerto Rico
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 1Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
-
Pierre Fabre DermatologyCompletedInfantile HemangiomaGermany, United States, France, Spain, Peru, Australia, Lithuania, Italy, Canada, Czech Republic, Hungary, Mexico, New Zealand, Poland, Romania, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States